Detalhe da pesquisa
1.
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
Lancet Oncol
; 25(1): e29-e41, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181810
2.
Epilepsy in gliomas: recent insights into risk factors and molecular pathways.
Curr Opin Neurol
; 36(6): 557-563, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37865836
3.
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter study.
J Neurooncol
; 163(2): 377-383, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37264256
4.
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.
J Neurooncol
; 162(2): 267-293, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36961622
5.
Antiangiogenic Therapy for Malignant Brain Tumors: Does It Still Matter?
Curr Oncol Rep
; 25(7): 777-785, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071295
6.
Health professional involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma.
Neurol Sci
; 44(5): 1749-1754, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36598619
7.
Patient and carer involvement in the formulation of research questions: findings from the Italian guideline on palliative care in adults with glioma.
Neurol Sci
; 44(7): 2491-2499, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36809422
8.
Neurotoxicity from Old and New Radiation Treatments for Brain Tumors.
Int J Mol Sci
; 24(13)2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445846
9.
Observational real-life study on regorafenib in recurrent glioblastoma: does dose reduction reduce toxicity while maintaining the efficacy?
J Neurooncol
; 160(2): 389-402, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36309895
10.
Ependymoma: Evaluation and Management Updates.
Curr Oncol Rep
; 24(8): 985-993, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35384591
11.
Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience.
Neurol Sci
; 43(3): 2031-2041, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34424427
12.
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient data.
Neurosurg Rev
; 45(5): 3067-3081, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35984552
13.
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 22(6): 813-823, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34000245
14.
Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.
Acta Neuropathol
; 141(6): 945-957, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33740099
15.
Systemic Therapy for Lung Cancer Brain Metastases.
Curr Treat Options Oncol
; 22(12): 110, 2021 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34693454
16.
Eribulin in brain metastases of breast cancer: outcomes of the EBRAIM prospective observational trial.
Future Oncol
; 17(26): 3445-3456, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34044585
17.
Adult brainstem glioma: a multicentre retrospective analysis of 47 Italian patients.
Neurol Sci
; 42(5): 1879-1886, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32954462
18.
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology).
Neurol Sci
; 42(2): 665-671, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32654010
19.
Blood-Brain Barrier in Brain Tumors: Biology and Clinical Relevance.
Int J Mol Sci
; 22(23)2021 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34884457
20.
Targeted Therapies in Rare Brain Tumours.
Int J Mol Sci
; 22(15)2021 Jul 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34360713